NRX Pharmaceuticals (NRXP) Receivables - Other (2023 - 2025)
NRX Pharmaceuticals (NRXP) posted quarterly Receivables - Other of $3.1 million for Q3 2025, up 51350.0% year-over-year from N/an in Q3 2024, and up 51350.0% quarter-over-quarter from $6000.0 in Q3 2024.
NRX Pharmaceuticals (NRXP) Receivables - Other (2023 - 2025) Analysis & Trends
NRX Pharmaceuticals (NRXP) has reported Receivables - Other for 3 consecutive years, with $3.1 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Receivables - Other rose 51350.0% year-over-year to $3.1 million; the TTM figure through Sep 2025 stood at $3.1 million (up 51350.0% YoY), while the FY2023 annual figure was $6000.0, changed N/A from the prior year.
- Receivables - Other improved to $3.1 million in Q3 2025 per NRXP's latest filing, from $6000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $3.1 million in Q3 2025 and bottomed at $6000.0 in Q4 2023.
- Historically, Receivables - Other has averaged $776250.0 across 3 years, with a median of $6000.0 in 2023.
- On a YoY basis, Receivables - Other climbed as much as 51350.0% in 2025 and fell as far as 51350.0% in 2025.
- NRX Pharmaceuticals' Receivables - Other stood at $6000.0 in 2023, then changed by 0.0% to $6000.0 in 2024, then jumped by 51350.0% to $3.1 million in 2025.
- Business Quant data shows NRXP's Receivables - Other at $3.1 million in Q3 2025, $6000.0 in Q3 2024, and $6000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | NRX Pharmaceuticals | 132.53 Mn | 105.83 Mn | 426,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 3.09 Mn |
| Sep 30, 2025 | 3.09 Mn |
| Sep 30, 2024 | 6,000.00 |
| Sep 30, 2024 | 6,000.00 |
| Jun 30, 2024 | 6,000.00 |
| Jun 30, 2024 | 6,000.00 |
| Dec 31, 2023 | 6,000.00 |
| Dec 31, 2023 | 6,000.00 |